We are analyzing https://link.springer.com/article/10.1007/s11010-013-1920-3.

Title:
Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells | Molecular and Cellular Biochemistry
Description:
Malignant melanoma is highly aggressive, and always resistant to conventional chemo-radiotherapy, which results in poor prognosis. As a specific antagonist of neurotensin receptor 1 (NTSR1), emerging evidences confirmed that SR48692 can reverse the pro-growth effect of neurotensin (NTS) by interrupting the interaction between NTS and NTSR1. A375 melanoma cell line was used in this experiment, and SR48692 was employed as the inhibitor of NTS/NTSR1 pathway. We detected the expression of NTSR1 by NTSR1 immunofluorescence and Western blot. After SR48692 treatment, cell proliferation was determined by cell counting, MTT assay and BrdU incorporation study, the cell cycle and apoptosis were performed by flow cytometry. At last Soft Agar Clonogenic assay and xenograft cancer mice model in vivo were used to confirm our result. In this study, we showed that NTSR1 is commonly high expressed in melanoma cells, but low expressed in normal immortalized human keratinocyte line HaCaT. SR48692 not only reduced cell proliferation and self-renewal potential in vitro, but also inhibited the tumor growth derived from A375 cells in NOD/SCID mice in vivo. Further, we originally reported that SR48692 inhibited cell proliferation through cell cycle arrest and apoptosis. Considering the favorable toxicity profile in vitro and in vivo though targeting NTS/NTSR1, SR48692 is worthy of further study and exploitation in melanoma treatment.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Telecommunications
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

article, neurotensin, pubmed, google, scholar, cas, cell, cancer, receptor, human, melanoma, cells, antagonist, apoptosis, ntsr, growth, access, proliferation, china, privacy, cookies, content, cycle, study, sci, gully, nonpeptide, publish, research, search, liu, effect, expression, vivo, vitro, open, int, res, university, data, information, log, journal, arrest, december, zhang, zhu, yaling, explore, malignant,

Topics {✒️}

month download article/chapter cancer cell lines cellular biochemistry aims reduced cell proliferation related subjects cell cycle arrest human colon cancer neurotensin receptor antagonist full article pdf human colon cancers privacy choices/manage cookies cell proliferation selective nonpeptide antagonist peptide neurotensin antagonists melanoma cells published human prostatic carcinoma rat prefrontal cortex human breast cancer human sclc cells article zhang human prostate cancer yaling liu cell cycle vitro clonal growth article molecular neurotensin receptor expression pro-growth effect tumor growth derived european economic area conventional chemo-radiotherapy emerging evidences confirmed nod/scid mice 7a-3p/bcl 5-bromo-2-deoxyuridine pi townsend cm jr ahmed-zaïd s antipsychotic drug responses silkworm genome biology neuroendocrine cancer oncostatin conditions privacy policy commonly high expressed indirect inhibitory effect military medical university check access instant access favorable toxicity profile brdu incorporation study nts/ntsr1 pathway targeting nts/ntsr1 accepting optional cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells
         description: Malignant melanoma is highly aggressive, and always resistant to conventional chemo-radiotherapy, which results in poor prognosis. As a specific antagonist of neurotensin receptor 1 (NTSR1), emerging evidences confirmed that SR48692 can reverse the pro-growth effect of neurotensin (NTS) by interrupting the interaction between NTS and NTSR1. A375 melanoma cell line was used in this experiment, and SR48692 was employed as the inhibitor of NTS/NTSR1 pathway. We detected the expression of NTSR1 by NTSR1 immunofluorescence and Western blot. After SR48692 treatment, cell proliferation was determined by cell counting, MTT assay and BrdU incorporation study, the cell cycle and apoptosis were performed by flow cytometry. At last Soft Agar Clonogenic assay and xenograft cancer mice model in vivo were used to confirm our result. In this study, we showed that NTSR1 is commonly high expressed in melanoma cells, but low expressed in normal immortalized human keratinocyte line HaCaT. SR48692 not only reduced cell proliferation and self-renewal potential in vitro, but also inhibited the tumor growth derived from A375 cells in NOD/SCID mice in vivo. Further, we originally reported that SR48692 inhibited cell proliferation through cell cycle arrest and apoptosis. Considering the favorable toxicity profile in vitro and in vivo though targeting NTS/NTSR1, SR48692 is worthy of further study and exploitation in melanoma treatment.
         datePublished:2013-12-20T00:00:00Z
         dateModified:2013-12-20T00:00:00Z
         pageStart:1
         pageEnd:8
         sameAs:https://doi.org/10.1007/s11010-013-1920-3
         keywords:
            Malignant melanoma
            Neurotensin
            NTSR1
            SR48692
            Cell proliferation
            Apoptosis
            Cell cycle
            Biochemistry
            general
            Cardiology
            Cancer Research
            Medical Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig5_HTML.gif
         isPartOf:
            name:Molecular and Cellular Biochemistry
            issn:
               1573-4919
               0300-8177
            volumeNumber:389
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yanli Zhang
               affiliation:
                     name:the Third Hospital of Hebei Medical University
                     address:
                        name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shunqin Zhu
               affiliation:
                     name:Southwest University
                     address:
                        name:Department of Life Science, Southwest University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liang Yi
               affiliation:
                     name:the Third Military Medical University
                     address:
                        name:Neurosurgery Department, Daping Hospital, the Third Military Medical University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yaling Liu
               affiliation:
                     name:the Third Hospital of Hebei Medical University
                     address:
                        name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Hongjuan Cui
               affiliation:
                     name:Southwest University
                     address:
                        name:State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells
      description: Malignant melanoma is highly aggressive, and always resistant to conventional chemo-radiotherapy, which results in poor prognosis. As a specific antagonist of neurotensin receptor 1 (NTSR1), emerging evidences confirmed that SR48692 can reverse the pro-growth effect of neurotensin (NTS) by interrupting the interaction between NTS and NTSR1. A375 melanoma cell line was used in this experiment, and SR48692 was employed as the inhibitor of NTS/NTSR1 pathway. We detected the expression of NTSR1 by NTSR1 immunofluorescence and Western blot. After SR48692 treatment, cell proliferation was determined by cell counting, MTT assay and BrdU incorporation study, the cell cycle and apoptosis were performed by flow cytometry. At last Soft Agar Clonogenic assay and xenograft cancer mice model in vivo were used to confirm our result. In this study, we showed that NTSR1 is commonly high expressed in melanoma cells, but low expressed in normal immortalized human keratinocyte line HaCaT. SR48692 not only reduced cell proliferation and self-renewal potential in vitro, but also inhibited the tumor growth derived from A375 cells in NOD/SCID mice in vivo. Further, we originally reported that SR48692 inhibited cell proliferation through cell cycle arrest and apoptosis. Considering the favorable toxicity profile in vitro and in vivo though targeting NTS/NTSR1, SR48692 is worthy of further study and exploitation in melanoma treatment.
      datePublished:2013-12-20T00:00:00Z
      dateModified:2013-12-20T00:00:00Z
      pageStart:1
      pageEnd:8
      sameAs:https://doi.org/10.1007/s11010-013-1920-3
      keywords:
         Malignant melanoma
         Neurotensin
         NTSR1
         SR48692
         Cell proliferation
         Apoptosis
         Cell cycle
         Biochemistry
         general
         Cardiology
         Cancer Research
         Medical Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-013-1920-3/MediaObjects/11010_2013_1920_Fig5_HTML.gif
      isPartOf:
         name:Molecular and Cellular Biochemistry
         issn:
            1573-4919
            0300-8177
         volumeNumber:389
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yanli Zhang
            affiliation:
                  name:the Third Hospital of Hebei Medical University
                  address:
                     name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shunqin Zhu
            affiliation:
                  name:Southwest University
                  address:
                     name:Department of Life Science, Southwest University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liang Yi
            affiliation:
                  name:the Third Military Medical University
                  address:
                     name:Neurosurgery Department, Daping Hospital, the Third Military Medical University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yaling Liu
            affiliation:
                  name:the Third Hospital of Hebei Medical University
                  address:
                     name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Hongjuan Cui
            affiliation:
                  name:Southwest University
                  address:
                     name:State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular and Cellular Biochemistry
      issn:
         1573-4919
         0300-8177
      volumeNumber:389
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:the Third Hospital of Hebei Medical University
      address:
         name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
         type:PostalAddress
      name:Southwest University
      address:
         name:Department of Life Science, Southwest University, Chongqing, China
         type:PostalAddress
      name:the Third Military Medical University
      address:
         name:Neurosurgery Department, Daping Hospital, the Third Military Medical University, Chongqing, China
         type:PostalAddress
      name:the Third Hospital of Hebei Medical University
      address:
         name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
         type:PostalAddress
      name:Southwest University
      address:
         name:State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yanli Zhang
      affiliation:
            name:the Third Hospital of Hebei Medical University
            address:
               name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
               type:PostalAddress
            type:Organization
      name:Shunqin Zhu
      affiliation:
            name:Southwest University
            address:
               name:Department of Life Science, Southwest University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Liang Yi
      affiliation:
            name:the Third Military Medical University
            address:
               name:Neurosurgery Department, Daping Hospital, the Third Military Medical University, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Yaling Liu
      affiliation:
            name:the Third Hospital of Hebei Medical University
            address:
               name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Hongjuan Cui
      affiliation:
            name:Southwest University
            address:
               name:State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
      name:Department of Life Science, Southwest University, Chongqing, China
      name:Neurosurgery Department, Daping Hospital, the Third Military Medical University, Chongqing, China
      name:Department of Dermatology, the Third Hospital of Hebei Medical University, Shijiazhuang, China
      name:State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(110)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.74s.

LINK . SPRINGER . COM {}